完整鼻内镜鼻窦手术联合阿司匹林脱敏可减少AERD患者总体糖皮质激素使用
本研究回顾性分析125例阿司匹林加重性呼吸疾病(AERD)患者,均接受完整鼻内镜鼻窦手术(ESS)后行阿司匹林脱敏(AD)。结果显示,与术前相比,术后长期每日口服泼尼松比例从32%降至13-24个月时的10%,平均日剂量从10.6±7.9 mg降至3.8±2.6 mg,高剂量和 medium-dose 吸入性糖皮质激素使用亦下降。
要点
- ESS后AD可显著降低AERD患者长期每日口服泼尼松的需求。
- 平均每日泼尼松剂量在AD后13-24个月较术前明显下降。
- 高剂量和 medium-dose 吸入性糖皮质激素使用比例亦减少。
核心结论
- 在AERD队列中,完整ESS后行AD观察到全身及局部/吸入性糖皮质激素使用减少。
研究设计与样本
- 回顾性图表综述的试点研究,纳入125例接受ESS后AD的AERD患者。
主要发现
- 每日口服泼尼松比例从术前32%降至AD后13-24个月的10%(McNemar检验=9.00,p=0.009)。
- 平均每日泼尼松剂量从术前10.6±7.9 mg降至AD后13-24个月的3.8±2.6 mg(Mann-Whitney U;W=122,p=0.01)。
- 高剂量吸入性糖皮质激素使用从18%降至7%, medium-dose 从36%降至22%(Pearson卡方=8.06,p=0.05)。
临床怎么用
- 对于AERD患者,完整ESS后行AD可能有助于减少长期糖皮质激素用量及其副作用。
局限性
- 为回顾性试点研究,样本量有限,需进一步前瞻性研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Aspirin-exacerbated respiratory disease (AERD) is an aggressive respiratory tract inflammatory disorder manifesting as asthma, chronic rhinosinusitis with nasal polyposis, and a respiratory sensitivity to aspirin and nonsteroidal anti-inflammatory drugs (NSAIDs). Corticosteroids, both systemic and topical/inhaled, are used to treat inflammation of the upper and lower airways. Our objective was to examine the potential impact of complete endoscopic sinus surgery (ESS) and aspirin desensitization (AD) on short-term and long-term corticosteroid use. METHODS: For this pilot study, a retrospective chart review of all patients with AERD who underwent ESS followed by AD was performed. Daily prednisone use, average daily prednisone dose, and inhaled corticosteroid use were analyzed at the following time points: preoperative, postoperative/pre-AD, and 2 to 3 months, 4 to 6 months, 7 to 12 months, and 13 to 24 months following AD. RESULTS: A total of 125 patients underwent ESS followed by AD. Compared to preoperatively, patients who underwent ESS and AD were less likely to be on daily prednisone at all time points and upon long-term follow-up (32% preoperatively vs 10% at 13 to 24 months, McNemar's test = 9.00, p = 0.009). Average daily prednisone dose decreased from 10.6 ± 7.9 mg preoperatively to 3.8 ± 2.6 mg at 13 to 24 months following AD (Mann-Whitney U; W = 122, p = 0.01). Similarly, high-dose and medium-dose inhaled corticosteroid use decreased from 18% to 7% and from 36% to 22% respectively (Pearson's chi-square = 8.06, p = 0.05). CONCLUSION: In our AERD cohort who underwent ESS followed by AD, there was an observed decrease in overall systemic and topical/inhaled corticosteroid use. These findings can have implications for treatment given the potentially hazardous side effects of corticosteroid use.
引用
- Bosso JV, Locke TB, Kuan EC, et al. Complete endoscopic sinus surgery followed by aspirin desensitization is associated with decreased overall corticosteroid use. Int Forum Allergy Rhinol. 2020. PMID: 32558306. doi:10.1002/alr.22604
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。